Juan M. Ortega-Legaspi - Publications

Changes in bloodstream infections in heart transplant recipients following the allocation guidelines change.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: February 09, 2026

Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomes.

Journal: International journal of cardiology. Congenital heart disease

Published: July 25, 2025

Cardiac Medication Prescription Pattern and Association With Transplant-free Survival in the Adult Fontan Population.

Journal: JACC. Advances

Published: March 03, 2025

Hemodynamic Support With the Impella 5.5 Acute Mechanical Circulatory Support Device.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: October 14, 2024

Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation.

Journal: Pediatric cardiology

Published: September 05, 2024

Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study.

Journal: Clinical transplantation

Published: October 25, 2023

Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices.

Journal: Current heart failure reports

Published: July 18, 2023

Combined heart liver transplantation in the patients with advanced liver disease and/or hepatocellular carcinoma: Why cannot liver pull the heart?

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 23, 2023

Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation.

Journal: Clinical transplantation

Published: April 27, 2023

Safety and Treatment Experience With Sodium/glucose Cotransporter-2 Inhibitors in Adult Patients With Congenital Heart Disease.

Journal: Journal of cardiac failure

Published: February 21, 2023

Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?

Journal: Annals of palliative medicine

Published: September 16, 2022

A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019.

Journal: Nature metabolism

Published: August 05, 2022